In neonates, particularly those born preterm, the lungs are often underdeveloped and lack adequate surfactant. This deficiency can lead to a condition known as Respiratory Distress Syndrome (RDS). Administering exogenous surfactant can significantly improve lung function and increase the chances of survival in these infants.
